Stock Analiz

Taysha Gene Therapies, Inc. (TSHA) stock forecast and price target

Price $4.10 · data as of November 13, 2026

12-month price target

Average target$13.00
Upside / downside+217.1%
Analysts13
ConsensusStrong buy
Low $9.00Average $13.00High $19.00

Gold marker: average target · white marker: today’s price ($4.10)

Analyst ratings

Strong buy 3Buy 10Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.43−35.9%$333330
Next fiscal year
ends December 31, 2027
$-0.39+10.3%$14M
Next quarter
ends December 31, 2026
$-0.10−43.5%$375000
Quarter after
ends March 31, 2027
$-0.10+6.0%$685710

Consensus of the analysts covering Taysha Gene Therapies, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.

Frequently asked questions

What is the Taysha Gene Therapies stock price target?

The average 12-month target from 13 analysts is $13.00, 217.1% above the current price of $4.10 Targets range from $9.00 to $19.00.

Is Taysha Gene Therapies a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Taysha Gene Therapies expected to earn?

Analysts expect EPS of $-0.43 for the fiscal year ending December 31, 2026 and $-0.39 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.